(Q73462124)
Statements
A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patients (English)
Varga Z
de Mulder P
Kruit W
Hegele A
Hofmann R
Lamers C
Warnaar S
Mala C
Ullrich S